Colorectal Cancer, Hepatitis C, Renal Cell Carcinoma
Conditions
Keywords
Hepatitis C, Renal Cell Carcinoma, Colorectal Cancer
Brief summary
The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).
Interventions
OTHERHepatitis C testing
Hepatitis C antibody, Hepatitis C RNA quantitative and for those who test positive Hepatitis C genotype
Sponsors
Schering-Plough
Henry Ford Health System
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months. * Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months
Exclusion criteria
* Patients who are unwilling to provide consent * Patients who decline to complete a questionnaire * Patient in who blood sample cannot be obtained * Diagnosis of renal cell carcinoma or colon cancer greater than 6 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of hepatitis C in renal cell carcinoma patients | 2 years | Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients |
Countries
United States
Outcome results
None listed